Universal Screening for Hepatitis C Virus in the ED Using a Best Practice Advisory

Introduction In 2019 the United States Preventive Services Task Force (USPSTF) released draft guidelines recommending universal hepatitis C virus (HCV) screening for individuals aged 18–79. We aimed to assess the efficacy of an emergency department-based HCV screening program, by comparing screening practices before and after its implementation. Methods We performed a retrospective cohort analysis of two temporally matched, 11-month study periods, corresponding to before and after the implementation of a best practice advisory (BPA). Patients were screened for anti-HCV antibody (Ab), and positive results were followed by HCV viral load (VL) testing. The primary implementation outcome was ED testing volume (number of tests performed/month). The primary screening outcomes were the seroprevalence of anti-HCV Ab and HCV VL. We describe data with simple descriptive statistics. Results The median age of patients was similar between periods (pre: 50 years [interquartile range [IQR] 34–62], post: 47 years [IQR 33–59]). Patients screened were more likely to be males in the pre-BPA period (Male, pre: 60%, post: 49%). During the pre-BPA study period, a total of 69,604 patients were seen in the ED, and 218 unique patients were screened for HCV (mean 19.8 tests/month). During the post-BPA study period, a total of 68,225 patients were seen in the ED, and 14,981 unique patients were screened for HCV (mean 1361.9 tests/month). Anti-HCV Ab seroprevalence was 23% (51/218) and 9% (1340/14,981) in the pre-BPA and post-BPA periods, respectively. In the pre-BPA period, six patients with a positive anti-HCV Ab level had follow-up VL testing (detectable in three). In the post-BPA period, reflex VL testing was performed in most patients (91%, 1225/1,340), and there were 563 patients with detectable VLs, indicating active infection. Conclusion Our study shows that using a universal BPA-driven screening protocol can dramatically increase the number of patients screened for HCV and increase the number of new HCV diagnoses.

[1]  D. Dewitt,et al.  Declining Use of Primary Care Among Commercially Insured Adults in the United States , 2020, Annals of Internal Medicine.

[2]  M. Krahn,et al.  The emergency department as a setting‐specific opportunity for population‐based hepatitis C screening: An economic evaluation , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[3]  Stephen R. Spriggs,et al.  CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[4]  M. Swain,et al.  Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department , 2020, Canadian journal of gastroenterology & hepatology.

[5]  Kristin N. Ray,et al.  Declining Use of Primary Care Among Commercially Insured Adults in the United States, 2008–2016 , 2020, Annals of Internal Medicine.

[6]  J. Schneider,et al.  Routine opt-out syphilis screening in the emergency department: A public health imperative. , 2019, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[7]  M. Cabana,et al.  Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement. , 2019, JAMA.

[8]  Diana M. Hendrickx,et al.  Screening for hepatitis C at the emergency department: Should babyboomers also be screened in Belgium? , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[9]  Jonathan Mermin,et al.  Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016 , 2018, Hepatology.

[10]  D. White,et al.  A Comparative Effectiveness Study of Two Nontargeted HIV and Hepatitis C Virus Screening Algorithms in an Urban Emergency Department , 2018, Annals of emergency medicine.

[11]  E. Cowan,et al.  Bundled HIV and Hepatitis C Testing in the Emergency Department: A Randomized Controlled Trial , 2018, The western journal of emergency medicine.

[12]  C. Andry,et al.  Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt‐out Hepatitis C Virus Screening Program , 2018, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[13]  V. Razuk,et al.  Results of a Hepatitis C Virus Screening Program of the 1945–1965 Birth Cohort in a Large Emergency Department in New Jersey , 2017, Open forum infectious diseases.

[14]  M. Phipps,et al.  Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[15]  S. Holmberg,et al.  Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  S. Kottilil,et al.  Treatment of hepatitis C: a systematic review. , 2014, JAMA.

[17]  Janet J. Hamilton,et al.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. Pawlotsky,et al.  EASL Recommendations on Treatment of Hepatitis C 2016. , 2017, Journal of hepatology.

[19]  H. Alter,et al.  Results of a Rapid Hepatitis C Virus Screening and Diagnostic Testing Program in an Urban Emergency Department. , 2016, Annals of emergency medicine.